Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Breast Neoplasm Female: full-pipeline trial registry
3 of 9 indexed Breast Neoplasm Female trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Breast Neoplasm Female: 9 US clinical trials tracked, 3 recruiting.
Breast Neoplasm Female is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Providence Health & Services, running 1 of these trials.
Enrollment posture brief
Registry condition breast-neoplasm-female
OPEN 3 | RECR 33% | LATE 1 | EARLY 1 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Breast Neoplasm Female lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Breast Neoplasm Female on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Breast Neoplasm Female is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Breast Neoplasm Female trials is spread across many organizations.
Providence Health & Services accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Breast Neoplasm Female trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.
-
Breast Neoplasm Female research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
Rna Diagnostics
NCT03524430
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Georgetown University
NCT06892275
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
University of Wisconsin, Madison
NCT03096418
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
Providence Health & Services
NCT03650894
THRIVE Breast Cancer App Study
Emory University
NCT03592771
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
University of Michigan
NCT05700006
Web-Base App To Improve Aromatase Inhibitor Adherence
University of Tennessee
NCT02957526
Study on Physical Activity's Relationship With Cancer and Cognition
University of Nebraska
NCT03980626
Mayo Designed Soft Tissue Ultrasound-Detectable Marker
Mayo Clinic
NCT04674852
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Breast Neoplasm Female records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Breast Neoplasm Female trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Breast Neoplasm Female page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Breast Neoplasm Female trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Providence Health & Services sponsors the most Breast Neoplasm Female trials on record, review their full trial history before evaluating a specific study. See Providence Health & Services's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Neoplasm Female condition card totals 9 registered trials; most-linked intervention Tailored Feedback Messages; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.